Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-005367
Filing Date
2025-02-24
Accepted
2025-02-24 19:55:07
Documents
1
Period of Report
2025-02-20

Document Format Files

Seq Description Document Type Size
1 form4-02242025_070203.html 4  
1 form4-02242025_070203.xml 4 5951
  Complete submission text file 0001415889-25-005367.txt   7331
Mailing Address 500 PLAZA DRIVE SECAUCUS NJ 07094
Business Address
Rona Jeffrey A (Reporting) CIK: 0001311404 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38085 | Film No.: 25658851

Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Issuer) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)